|
Cencora ThinkLive Cell and Gene Therapy Virtual Summit 2025
|
|
|
Join us for our second cell and gene therapy (CGT) summit as we delve into topics at the forefront of the industry!
This two-day virtual summit will bring together the expertise of Cencora and global leaders, providers, and healthcare experts. Our esteemed speakers will provide insights into the advancements shaping the future of healthcare as well as how, together, we can build solutions for tomorrow’s therapies.
Date: May 20-21, 2025
Time: 8:00am – 11:00am PDT / 11:00am – 2:00pm EDT / 4:00pm – 7:00pm BST / 5:00pm – 8:00pm CET
Location: Virtual
|
|
|
|
|
|
|
Addressing market access challenges as CGTs expand to larger patient populations
|
As CGTs could begin to treat larger patient populations, the U.S. market faces a multitude of market access challenges that must be addressed to realize their full potential. For your commercialization strategy to succeed, you should consider the strategies in this article.
|
|
|
|
|
|
|
The future promise of advanced therapies in ophthalmology
|
Six years after the first approved gene therapy in ophthalmology, the field is seeing a flurry of activity in innovative CGT studies addressing high unmet needs. Here’s what could be in store for the future.
|
|
|
|
|
|
|
|
Let's connect
|
|
Schedule some time with our cell and gene therapy experts today. We look forward to hearing from you.
|
|
|
|
|
|
| |
|
Want to reach 108,000+ biopharma executives with your own message? Get the media kit or contact us directly at advertising@industrydive.com.
About this email: You are receiving this message as part of your complimentary newsletter subscription to BioPharma Dive. If you no longer wish to receive the daily newsletter, you can switch to a weekly subscription or unsubscribe. See our full privacy policy. BioPharma Dive is a product of TechTarget, Inc. and its subsidiaries, 275 Grove St. Newton, MA, 02466
|
|
| |
|
